Page 5 - சோஃபி டெஸ்மாரைஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சோஃபி டெஸ்மாரைஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சோஃபி டெஸ்மாரைஸ் Today - Breaking & Trending Today

Investegate |Montreal Heart Institute Announcements | Montreal Heart Institute: Colchicine reduces the risk of COVID-19-related complications

Investegate announcements from Montreal Heart Institute, Colchicine reduces the risk of COVID-19-related complications ....

South Africa , United States , Sophie Desmarais , Jean Claude Tardif , Camille Turbide , Christy Maginn , Montreal Heart Institute , Us National Institutes Of Health , Research Center , Melinda Gates Foundation , Dacima Software Inc , Pharmascience Inc , Montreal Health Innovations Coordinating Center , Blood Institute , National Heart , Principal Investigator , South America , Dacima Software , Electronic Data Capture , Dacima Clinical Suite , Therapeutics Accelerator , Investegate Announcements , Investegate Company Announcements , Globe Newswire , Globenewswire And , ஒன்றுபட்டது மாநிலங்களில் ,

Colchicine reduces the risk of COVID-19-related complications

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Colchicine reduces the risk of COVID-19-related complications
Montreal Heart InstituteJanuary 23, 2021 GMT
MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of death or hospitalizations in patients with COVID-19 compared to placebo. This result obtained for the global study population of 4488 patients approached statistical significance. The analysis of the 4159 patients in whom the diagnosis of COVID-19 was proven by a naso-pharyngeal PCR test has shown that the use of colchicine was associated with statistically significant reductions in the risk of death or hospitalization compared to placebo. In these patients with a proven diagnosis of ....

South Africa , United States , Sophie Desmarais , Jean Claude Tardif , Camille Turbide , Christy Maginn , Montreal Heart Institute , Us National Institutes Of Health , Research Center , Melinda Gates Foundation , Dacima Software Inc , Pharmascience Inc , Montreal Health Innovations Coordinating Center , Blood Institute , National Heart , Principal Investigator , South America , Dacima Software , Electronic Data Capture , Dacima Clinical Suite , Therapeutics Accelerator , Products And Services , Coronavirus Pandemic , Product Testing , Diagnosis And Treatment , Globe Newswire ,

Colchicine reduces the risk of COVID-19-related complications Positive results from COLCORONA trial show that colchicine is the only effective oral medication for treating non-hospitalized patients

Article content
MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of death or hospitalizations in patients with COVID-19 compared to placebo. This result obtained for the global study population of 4488 patients approached statistical significance. The analysis of the 4159 patients in whom the diagnosis of COVID-19 was proven by a naso-pharyngeal PCR test has shown that the use of colchicine was associated with statistically significant reductions in the risk of death or hospitalization compared to placebo. In these patients with a proven diagnosis of COVID-19, colchicine reduced hospitalizations by 25%, the need for mechanical ventilation by 50%, and deaths by 44%. This major scientific discovery makes colchicine the world’s first oral dr ....

South Africa , United States , Sophie Desmarais , Jean Claude Tardif , Camille Turbide , Christy Maginn , Montreal Heart Institute , Us National Institutes Of Health , Research Center , Melinda Gates Foundation , Dacima Software Inc , Pharmascience Inc , Montreal Health Innovations Coordinating Center , Blood Institute , National Heart , Principal Investigator , South America , Montreal Heart , Dacima Software , Electronic Data Capture , Dacima Clinical Suite , Therapeutics Accelerator , ஒன்றுபட்டது மாநிலங்களில் , சோஃபி டெஸ்மாரைஸ் , ஜீன் கிளாட் தாற்டிப் , கிறிஸ்டி ம்யாஜிந் ,

Sophie Desmarais vend son condo 11M$

Sophie Desmarais vend son condo 11M$
journaldemontreal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journaldemontreal.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Mount Royal , British Columbia , Sophie Desmarais , Liza Kaufman , Paul Desmarais , Liza Kaufman Sotheby , Foundation Jasmine King Sophie Desmarais , Family House , Off Liza Kaufman Sotheby , Canadian City , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஏற்ற அரச , பிரிட்டிஷ் கொலம்பியா , சோஃபி டெஸ்மாரைஸ் , லிசா காஃப்மந் , பால் டெஸ்மாரைஸ் , குடும்பம் வீடு , கனடியன் நகரம் ,

Colchicine, a gout drug, shows preliminary promise for Covid-19

National Institute of Allergy and Infectious Diseases, NIH
A press release from a Canadian research group raised hopes that treating people recently diagnosed with Covid-19 with colchicine, a drug commonly used to treat gout, could reduce the risk they will need to be hospitalized.
But outside experts said the data provided were too limited to draw conclusions, leading to discussions of the risks of conducting science via press release, instead of in more detailed manuscripts in peer-reviewed journals. All hoped that colchicine, a cheap and globally available generic medicine with manageable side effects, would prove to be beneficial.
“I’m not, ‘Oh, I don’t buy it’,” said Ashish Jha, dean of the Brown University School of Public Health. “It’s possible. There’s enough plausibility here. This could be a real finding, and if it is that would be great. But this press release doesn’t get us there.” ....

New York , United States , San Francisco , Sophie Desmarais , Nahid Bhadelia , Eric Topol , Jean Claude Tardif , Marc Pfeffer , Ethan Weiss , Steven Nissen , Ashish Jha , Craig Spencer , Montreal Heart Institute , University Of California , Scripps Research Translational Institute , Brown University School Of Public Health , University Of Minnesota David Boulware , Boston University , Melinda Gates Foundation , Harvard Medical School , Us National Heart , Presbyterian Columbia University Medical Center , Blood Institute , Brown University School , Global Health , Emergency Medicine ,